Petro Giržado veterinarijos farmacijos vaistinė Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 147,256 |
| 49,249 |
| 834 |
| 748 |
| 250 |
| 35.37 |
| 0.51 |
| 42,887 |
| 3,942 |
| 2,362 |
| 44,467 |
| 2024 |
|---|
| 135,726 |
| 126,847 |
| 14,358 |
| 13,617 |
| 12,726 |
| 37.80 |
| 10.03 |
| 56,504 |
| 5,049 |
| 3,156 |
| 58,310 |
| 2025 |
|---|
| 133,691 |
| 122,652 |
| -7,965 |
| -8,041 |
| -7,377 |
| 41.23 |
| -6.01 |
| 78,463 |
| 5,949 |
| 29,505 |
| 54,538 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 133,691 |
| 122,652 |
| -7,965 |
| -8,041 |
| -7,377 |
| 41.23 |
| -6.01 |
| 78,463 |
| 5,949 |
| 29,505 |
| 54,538 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
133,691 €-2 % *
Sales per employee (€)
122,652 €-3 % *
Profit before tax (€)
-7,965 €-155 % *
Net Profit (€)
-8,041 €-159 % *
Profit per employee (€)
-7,377 €-158 % *
Total profitability (%)
41.23 %9.07 % *
Net profitability (%)
-6.01 %-159.92 % *
Equity (€)
78,463 €39 % *
Amounts Payable And Liabilities (€)
5,949 €18 % *
Non-current Assets (€)
29,505 €835 % *
CurrentAssets (€)
54,538 €-6 % *
